Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

A Boston Hedge Fund Just Made $950 Million On One Stock Today

Julia La RocheJul 23, 2014, 20:34 IST

Reuters/ Brian SnyderAdage Capital is located on the 52nd floor of the John Hancock Tower

Shares of Puma Biotechnology (PBYI) are going absolutely bonkers this morning following a successful trial of a breast cancer drug.

The stock surged about 283%, or about $167, since the opening bell.

At least one hedge fund is probably really pleased with this investment.

The largest shareholder of Puma Biotechnology is Adage Capital Management, a Boston-based hedge fund founded by Phil Gross and Robert Atchinson.

According to the latest 13F data, Adage last held 5,686,668 shares. That means they have made about $950 million on the position since the opening bell today.

Adage first reported its position in Puma Biotechnology on December 31, 2012. The fund held about 5.2 million shares then. From that time until yesterday's market close, shares of Puma Biotechnology have risen 214%.

And all those who sold out of the position before this news broke are probably kicking themselves right about now.